Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02937545 · ClinicalTrials.gov registry record · NA
Delivery of Pharmacogenetic Testing in a Community Pharmacy Setting
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 190
- Enrollment target
NCT02937545 is a NA study that has completed, run by Duke University. The registered enrollment target is 190 participants.
The verdict
NCT02937545, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
Study Summary
This study aims to compare patient use of and satisfaction with community pharmacist-delivered pharmacogenetic (PGx) testing delivered along or as part of a medication therapy management (MTM) service. Pharmacist and patient outcome measures will be collected by surveys, interviews, and review of pharmacy records.
Interventions
- OTHER Pharmacogenetic testing
- OTHER Medication Therapy Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2017-02-22 |
| Est. Completion | 2019-09-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02937545
The ClinicalTrials.gov registry entry for NCT02937545 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pharmacogenetic testing is the first listed.
NCT02937545 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02937545 about?
NCT02937545 is a clinical study titled "Delivery of Pharmacogenetic Testing in a Community Pharmacy Setting". This study aims to compare patient use of and satisfaction with community pharmacist-delivered pharmacogenetic (PGx) testing delivered along or as part of a medication therapy management (MTM) service. Pharmacist and patient outcome measures will be collected by surveys, interviews, and review of ph...
What is the current status of trial NCT02937545?
This trial is currently completed. It is a NA study. The enrollment target is 190 participants. The study started on 2017-02-22. Estimated completion is 2019-09-10.
What interventions are being tested in trial NCT02937545?
The interventions under investigation include: Pharmacogenetic testing (OTHER), Medication Therapy Management (OTHER).
Who is sponsoring clinical trial NCT02937545?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.